Skip to main content
. 2015 Dec 28;7(4):4298–4309. doi: 10.18632/oncotarget.6774

Table 1. Distinct core modules driving two ovarian cancer subtypes biology and clinical outcome.

Main module 5yr-survival rate
Metabolism NDRG1 RB1 ZHX1 Stage I–IV Stage III–IV
Subtype 1 × 16.7% 15.4%
Subtype 2 12.7% 11.7%